中国医学创新  2025, Vol. 22 Issue (8): 59-62    DOI: 10.3969/j.issn.1674-4985.2025.08.014
Clinical research Current Issue | Archive | Adv Search |
Effects of Empagliflozin Combined with Irbesartan on Renal Injury Markers in Obesity Patients with Diabetic Nephropathy
AI Lijuan, WU Xingxing, ZHOU Yingying
First-author's address: Department of Pharmacy, Fuzhou Medical Science Institute, Fuzhou 344000, China
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five      Postcodes: 100055